From Killing Cancer Cells to Calming Alzheimer’s: Is Cannabis the Next Medical Miracle?
— Marc Landers (@marclanders) June 14, 2025
1. Anti-Cancer Properties of CBD:
Osteosarcoma (Bone Cancer): CBD demonstrates multi-faceted anti-cancer effects against osteosarcoma cells in laboratory settings and animal models.
"CBD… pic.twitter.com/xtZqyXq4CA
From Killing Cancer Cells to Calming Alzheimer’s: Is Cannabis the Next Medical Miracle?
1. Anti-Cancer Properties of CBD: Osteosarcoma (Bone Cancer): CBD demonstrates multi-faceted anti-cancer effects against osteosarcoma cells in laboratory settings and animal models.
"CBD slowed down the growth and spread of osteosarcoma cells in lab tests."
"CBD increased cell death (apoptosis) in osteosarcoma cells and affected proteins related to cell death."
"In mice with osteosarcoma, CBD slowed tumor growth and increased cancer cell death."
"CBD prevented osteosarcoma cells from moving or spreading."
Oral Cancer: Strong evidence suggests CBD's effectiveness in inhibiting and eradicating oral cancer cells.
"CBD can slow or stop oral cancer cell growth by damaging their DNA."
"Stronger doses (25 µM or higher) were very effective at killing cancer cells, and effects got stronger over time."
The source suggests "CBD might be a new way to treat oral cancer."
2. Efficacy in Neurological Disorders:
Drug-Resistant Epilepsy (DRE): Cannabis oil, particularly a mix of CBD and THC, has shown remarkable success in achieving seizure freedom in DRE patients.
"19 patients with DRE... achieved SF (seizure free): 15 kids and 4 adults."
"On average, patients were seizure-free for about 245 days, often in stretches of at least 90 days."
"Five patients stayed seizure-free for a year or more."
Crucially, "Three patients were able to stop all other epilepsy medicines."
Additionally, many patients experienced "at least 50% fewer seizures," with reductions continuing over time. Most seizure types improved, with complex motor seizures being an exception.
Parkinson's Disease (PD): A survey in France indicates significant patient-reported benefits for common PD symptoms.
"Many PD patients in France find cannabis and CBD helpful, especially for sleep, pain, and stiffness."
The need for improved communication between doctors and patients and safer legal access is highlighted.
Alzheimer's Agitation: A cannabis-based spray (nabiximols/Sativex) appears to be a safe and practical option for managing agitation in Alzheimer's patients.
"The spray was safe—no side effects or safety issues were reported."
"The results show nabiximols (Sativex) is practical and safe to use for AD patients with agitation."
3. Mental Health and Quality of Life Improvements:
Obsessive-Compulsive Disorder (OCD): A new study indicates that medical cannabis can significantly enhance quality of life for OCD patients.
"New study shows BIG improvements in quality of life, mood, and sleep!"
Specific improvements noted include "General health," "Mood and depression," "Sleep," and "Anxiety."
4. Increasing Adoption Among Seniors with Chronic Conditions:
Growing Use: Cannabis use among US seniors has nearly doubled in two years, largely driven by its perceived benefits for chronic illnesses.
"The most dramatic increase came from people with chronic obstructive pulmonary disease (COPD), whose usage doubled from 6.4% to 13.5%."
"People with chronic conditions like cancer, diabetes, heart disease, and high blood pressure also reported using cannabis more."
"And those dealing with two or more chronic illnesses saw use rise from 3.5% to 8.2%."
The bulletin posits that while greater availability plays a role, the "real reason" for this increase is the perceived therapeutic value for managing chronic conditions.
Conclusion and Implications:
The presented sources strongly suggest that cannabis, particularly CBD, is emerging as a versatile therapeutic agent with significant potential across multiple medical domains. Its demonstrated anti-proliferative and pro-apoptotic effects in various cancer types, its ability to dramatically reduce seizures in drug-resistant epilepsy, and its reported benefits for symptoms of Parkinson's, Alzheimer's agitation, and OCD highlight a broad spectrum of applications.
The increasing self-reported use among seniors with chronic conditions further underscores a growing patient-led recognition of its efficacy. However, the recurring theme of the need for better communication between healthcare providers and patients, alongside safe and legal access, indicates that while the science is advancing rapidly, regulatory and clinical integration still require significant development. These findings reinforce the notion that cannabis could indeed be "the next medical miracle," necessitating continued research and thoughtful policy development.
